BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global B - Cell Chronic Lymphocytic Leukemia Treatment Market – Forecast to 2030,’ thoroughly examines the B - Cell Chronic Lymphocytic Leukemia Treatment industry to provide essential data & information for the targeted readers

The latest market analysis report published by Reports and Data, titled ‘Global Diffuse Large B-Cell Lymphoma (DLBCL) Treatment Market – Forecast to 2030,’ thoroughly examines the Diffuse Large B-Cell Lymphoma (DLBCL) Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Pressure Ulcer Market – Forecast to 2030,’ thoroughly examines the Pressure Ulcer industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Sanfilippo Treatment Market – Forecast to 2030,’ thoroughly examines the Sanfilippo Treatment industry to provide essential data & information for the targeted readers.

Lipocine Inc. announced today that it will participate in the Cantor Neurology & Psychiatric Conference (October 6-7) in San Francisco.

IHEEZO™ Represents the First Approved Use in the U.S. Ophthalmic Market of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for the U.S. Ophthalmic Market in Nearly 14 Years.

Sept. 27, 2022 18:21 UTC Immunis, Inc., a private biotech company generating an innovative treatment for age and disease-related immune decline, announces that its Chairman, Dr. Hans Keirstead, delivered a keynote on behalf of the National Institute of Child Sexual Assault at the UN General Assembly in New York City.

Zentalis™ Pharmaceuticals, Inc. today announced the promotion of co-founder Kevin Bunker, Ph.D., to Chief Scientific Officer.

The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients with RET -fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC).

During a special event, The Feinstein Institutes for Medical Research, the research home of Northwell Health, and Governor Kathy Hochul announced the completion of a $35 million, 20,000-square-foot renovation project meant to energize future breakthroughs in bioelectronic medicine.